Abstract
Cytochromes P450 (P450s) contribute to the metabolic activation and inactivation of various endogenous substrates. Despite years of research, the physiological role of CYP2S1 remains unknown. CYP2S1 has demonstrated NADPH P450-reductase-independent metabolism of cyclooxygenase (COX)-derived prostaglandins [e.g., prostaglandin G2 (PGG2)] at nanomolar concentrations. Arachidonic acid is converted to prostaglandin precursors [PGG2 and prostaglandin H2 (PGH2)] through COX. These precursors are used to synthesize numerous prostanoids, including PGE2. Prostaglandin E2 (PGE2) promotes cell proliferation and cell migration and inhibits apoptosis. CYP2S1 metabolism of PGG2 presumably sequesters PGG2 and PGH2, making them unavailable for synthesis of prostanoids such as PGE2. Whether CYP2S1 contributes to prostaglandin metabolism and influences cell physiological remains to be determined. The purpose of this study was to evaluate the physiological role of CYP2S1, if any, in human bronchial epithelial cells [SV40-derived bronchial epithelial cell line (BEAS-2B)]. To do this, we used small interfering RNA to deplete CYP2S1 mRNA and protein by approximately 75% and evaluated the impact of CYP2S1 depletion on cell proliferation and migration. CYP2S1 depletion enhanced both cell proliferation and migration in BEAS-2B cells. Consistent with the proposed role of CYP2S1 in PGE2 synthesis, the reduction in CYP2S1 expression doubled intracellular PGE2 levels. Pharmacological administration of PGE2 enhanced cell proliferation in BEAS-2B cells but failed to promote migration. Our data reveal an important role for CYP2S1 in the regulation of cell proliferation and migration, occurring in part through modulation of prostaglandin synthesis.
Footnotes
This work was supported in part by the Society of Toxicology Colgate-Palmolive Postdoctoral Fellowship Award in In Vitro Toxicology (to A.M.R.) and by New Mexico State University startup funds. Graduate (to T.M.F.) and undergraduate (to N.B.) financial support was provided through the Minority Biomedical Research Support-Research Initiative for Scientific Enhancement (RISE)-New Mexico State University RISE to Excellence Grant, National Institutes of Health National Institute of General Medical Sciences [Grant R25-GM061222].
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
↵ The online version of this article (available at http://dmd.aspetjournals.org) contains supplemental material.
ABBREVIATIONS:
- P450
- cytochrome P450
- COX
- cyclooxygenase
- LOX
- lipoxygenase
- PGG2
- prostaglandin G2
- PGH2
- prostaglandin H2
- PGE2
- prostaglandin E2
- PGD2
- prostaglandin D2
- EP
- E prostanoid receptor
- shRNA
- short hairpin RNA
- UTR
- untranslated region
- SCRAM
- scrambled control small interfering RNA
- qRT-PCR
- quantitative real-time polymerase chain reaction
- PBS
- phosphate-buffered saline
- BCA
- bicinchoninic acid
- GAPDH
- glyceraldehyde-3-phosphate dehydrogenase
- MTT
- 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
- AA
- arachidonic acid
- 12-HHT
- 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid
- TXA2
- thromboxane A2
- MDA
- malondialdehyde
- AC
- adenylate cyclase
- ERK
- extracellular signal-regulated kinase
- Src
- sarcoma
- siRNA
- small interfering RNA.
- Received April 26, 2012.
- Accepted August 3, 2012.
- Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|